Koichi Mitsuya
Overview
Explore the profile of Koichi Mitsuya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
851
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kinoshita M, Fushimi Y, Masumoto T, Sasaki K, Sekita T, Natsume A, et al.
Magn Reson Med Sci
. 2024 Nov;
PMID: 39567017
Purpose: To re-evaluate images recovered from JCOG0911, a randomized phase 2 trial for newly diagnosed glioblastoma (nGBM) conducted by the Japan Clinical Oncology Group (JCOG) Brain Tumor Study Group. Methods:...
2.
Nagashima T, Yamaguchi K, Urakami K, Shimoda Y, Ohnami S, Ohshima K, et al.
Sci Rep
. 2024 Oct;
14(1):23898.
PMID: 39396060
In cancer genome analysis, identifying pathogenic alterations and assessing their effects on oncogenic processes is important. Although whole exome sequencing (WES) can effectively detect such changes, driver alterations could not...
3.
Kanematsu R, Hanakita J, Takahashi T, Minami M, Mitsuya K
Surg Neurol Int
. 2024 Sep;
15:312.
PMID: 39246760
Background: Intramedullary spinal cord metastases (ICSMs) are very rarely curable; these patients typically have very short-term survival rates. Here, a 22-year-old male with non-small-cell lung cancer (NSCLC) later developed ICSM...
4.
Hirose T, Deguchi S, Yasui K, Inoue M, Onoe T, Ogawa H, et al.
BMC Cancer
. 2024 Aug;
24(1):940.
PMID: 39095756
Background: Stereotactic irradiation has become the mainstay treatment for brain metastases (BM), and whole-brain radiotherapy (WBRT) is often used for symptom palliation. However, the survival time of patients with BM...
5.
Deguchi S, Mitsuya K, Saito R
No Shinkei Geka
. 2024 Jul;
52(4):699-704.
PMID: 39034508
The frequency of identification of asymptomatic meningiomas is increasing owing to the advancement and widespread use of CT and MRI. The first choice for asymptomatic meningiomas is observation. Approximately 70%...
6.
Deguchi S, Akiyama Y, Mitsuya K, Ikeya T, Hozumi C, Iizuka A, et al.
Anticancer Res
. 2024 Apr;
44(5):1983-1994.
PMID: 38677762
Background/aim: Brain metastasis, a leading cause of cancer death, is a clinical challenge. Recently, genetic characterization of brain metastatic lesions based on next generation sequencing-based advanced technologies, such as single-cell...
7.
Suzuki T, Deguchi S, Matsushima K, Katsumata S, Kojima H, Koki M, et al.
World Neurosurg
. 2024 Apr;
186:e353-e359.
PMID: 38570091
Background: In the treatment of nonsmall cell lung cancer (NSCLC), a disease-free survival of 5 years is a criterion for cure. This study aimed to evaluate the characteristics and outcomes...
8.
Sato Y, Deguchi S, Norose T, Oishi T, Mitsuya K, Sugino T, et al.
Nagoya J Med Sci
. 2023 Dec;
85(4):828-835.
PMID: 38155632
Gliosarcoma (GS), a morphological variant of glioblastoma, pathologically shows a biphasic pattern with gliomatous and sarcomatous components. It has been reported that GS has much higher metastatic capacity than glioblastoma....
9.
Hozumi C, Iizuka A, Ikeya T, Miyata H, Maeda C, Ashizawa T, et al.
Cancer Genomics Proteomics
. 2023 Dec;
21(1):88-101.
PMID: 38151294
Background/aim: Recently, inactivating somatic mutations of SWI/SNF chromatin-remodeling genes in cancers have been reported. However, few studies have been performed regarding the immunological analysis of the tumor microenvironment (TME) in...
10.
Sato Y, Mitsuya K, Kakuda Y, Oishi T, Deguchi S, Sugino T, et al.
J Neurol Surg Rep
. 2023 Oct;
84(3):e103-e108.
PMID: 37901278
Primary intraosseous meningioma (PIM) is a rare tumor that arises in the skull. Histopathologically, it is generally described as a slow-growing, benign lesion. However, on rare occasions, PIM presents as...